Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2008 4
2009 1
2010 3
2011 4
2012 5
2013 2
2014 3
2015 6
2016 4
2017 6
2018 6
2019 6
2020 9
2021 14
2022 15
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Beelen DW, Stelljes M, Reményi P, Wagner-Drouet EM, Dreger P, Bethge W, Ciceri F, Stölzel F, Junghanß C, Labussiere-Wallet H, Schaefer-Eckart K, Grigoleit GU, Scheid C, Patriarca F, Rambaldi A, Niederwieser D, Hilgendorf I, Russo D, Socié G, Holler E, Glass B, Casper J, Wulf G, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, La Rocca U, Finke J, Benedetti F, Pichlmeier U, Klein A, Baumgart J, Markiewicz M. Beelen DW, et al. Among authors: hilgendorf i. Am J Hematol. 2022 Aug;97(8):1023-1034. doi: 10.1002/ajh.26620. Epub 2022 Jun 8. Am J Hematol. 2022. PMID: 35617104 Free article. Clinical Trial.
Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie.
Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F. Laws HJ, et al. Among authors: hilgendorf i. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):588-644. doi: 10.1007/s00103-020-03123-w. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 32350583 Free PMC article. German. No abstract available.
Erratum zu: Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie.
Laws HJ, Baumann U, Bogdan C, Burchard G, Christopeit M, Hecht J, Heininger U, Hilgendorf I, Kern W, Kling K, Kobbe G, Külper W, Lehrnbecher T, Meisel R, Simon A, Ullmann A, de Wit M, Zepp F. Laws HJ, et al. Among authors: hilgendorf i. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Oct;63(10):1300-1302. doi: 10.1007/s00103-020-03179-8. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 32638032 Free PMC article. German. No abstract available.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Beelen DW, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet EM, Hauptrock B, Dreger P, Luft T, Bethge W, Vogel W, Ciceri F, Peccatori J, Stölzel F, Schetelig J, Junghanß C, Grosse-Thie C, Michallet M, Labussiere-Wallet H, Schaefer-Eckart K, Dressler S, Grigoleit GU, Mielke S, Scheid C, Holtick U, Patriarca F, Medeot M, Rambaldi A, Micò MC, Niederwieser D, Franke GN, Hilgendorf I, Winkelmann NR, Russo D, Socié G, Peffault de Latour R, Holler E, Wolff D, Glass B, Casper J, Wulf G, Menzel H, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, Grass S, Iori AP, Finke J, Benedetti F, Pichlmeier U, Hemmelmann C, Tribanek M, Klein A, Mylius HA, Baumgart J, Dzierzak-Mietla M, Markiewicz M. Beelen DW, et al. Among authors: hilgendorf i. Lancet Haematol. 2020 Jan;7(1):e28-e39. doi: 10.1016/S2352-3026(19)30157-7. Epub 2019 Oct 9. Lancet Haematol. 2020. PMID: 31606445 Clinical Trial.
Immunization in the adult immunocompromised host.
Löbermann M, Boršo D, Hilgendorf I, Fritzsche C, Zettl UK, Reisinger EC. Löbermann M, et al. Among authors: hilgendorf i. Autoimmun Rev. 2012 Jan;11(3):212-8. doi: 10.1016/j.autrev.2011.05.015. Epub 2011 May 18. Autoimmun Rev. 2012. PMID: 21621004 Review.
Long-term follow-up after allogeneic stem cell transplantation.
Hilgendorf I, Greinix H, Halter JP, Lawitschka A, Bertz H, Wolff D. Hilgendorf I, et al. Dtsch Arztebl Int. 2015 Jan 23;112(4):51-8. doi: 10.3238/arztebl.2015.0051. Dtsch Arztebl Int. 2015. PMID: 25797423 Free PMC article. Review.
Pomalidomide combinations are a safe and effective option after daratumumab failure.
Brioli A, Gengenbach L, Mancuso K, Binder M, Ernst T, Heidel FH, Stauch T, Zamagni E, Hilgendorf I, Hochhaus A, Engelhardt M, von Lilienfeld-Toal M. Brioli A, et al. Among authors: hilgendorf i. J Cancer Res Clin Oncol. 2023 Aug;149(9):6569-6574. doi: 10.1007/s00432-023-04637-x. Epub 2023 Feb 13. J Cancer Res Clin Oncol. 2023. PMID: 36781500 Free PMC article.
[Long-term survival in cancer: definitions, concepts, and design principles of survivorship programs].
Bergelt C, Bokemeyer C, Hilgendorf I, Langer T, Rick O, Seifart U, Koch-Gromus U. Bergelt C, et al. Among authors: hilgendorf i. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Apr;65(4):406-411. doi: 10.1007/s00103-022-03518-x. Epub 2022 Mar 17. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022. PMID: 35301545 Free PMC article. Review. German.
81 results